The awards recognize IKS Health as an industry leader based on client experiences across 18 key performance indicators such as innovation, strategic alignment of client goals, implementation, trust, and client support

IKS Health, a healthcare solutions provider that offers a care enablement platform, achieved the top ranking for clinical documentation and medical coding services in the 2024 Black Book Market Research User Survey. IKS Health maintained its leading position for the 11th year in the clinical documentation category and the second consecutive year for the medical coding services category.

IKS Health ranked first among 20 competitors for the following performance indicators:

• Innovation
• Strategic Alignment of Client Goals
• Client Relationship and Cultural Fit
• Trust, Transparency, Accountability and Ethics
• Breadth of Offerings
• Deployment and Implementation
• Customization
• Scalability
• Support and Customer Care
• Marginal Value Adds

“We are honored to be recognized for our commitment to alleviating the administrative, clinical, and operational burdens faced by healthcare providers,” said Sachin Gupta, CEO of IKS Health. “Our top rankings in innovation, strategic alignment, implementation, trust, and client support reflect our dedication to enhancing the healthcare experience for both providers and patients. We thank Black Book Research for this acknowledgment and extend our gratitude to our clients for their continued support.”

Read the full reports here. IKS Health’s clinical documentation and coding suite are part of the IKS Care Enablement Platform which integrates technology and human expertise to create better outcomes for both healthcare organizations and their patients. To learn more about the IKS Health Care Enablement Platform, click here.

About Black Book Research

Black Book Research is a full-service healthcare-centric market research and public opinion research company and premier provider of competitive intelligence, market research, opinion mining, sentiment analysis, services evaluation, and strategic consulting services to Fortune 2000 companies worldwide. Black Book Research offers complete quantitative and qualitative research services, excelling in the design of customized surveys and research approaches to meet specific needs in healthcare.

About IKS Health

IKS Health takes on the chores of healthcare—spanning administrative, clinical, and operational burdens—so that clinicians can focus on their core tasks of medical care delivery. Combining pragmatic technology and dedicated experts, IKS enables stronger, financially sustainable enterprises. IKS’s Care Enablement Platform delivers data-driven value and expertise across the care journey, and IKS is a partner for clinician enterprises looking to effectively scale, improve quality and achieve cost savings through forward-thinking solutions. Founded in 2006, IKS’s technology-enabled solutions and global workforce supports large health systems, medical groups and risk bearing entities across the United States. For more information, visit ikshealth.com.

Inventurus Knowledge Solutions Limited is proposing, subject to receipt of requisite approvals, market conditions and other considerations, to make an initial public offer of its equity shares, and has filed a draft red herring prospectus (“DRHP”) with the Securities and Exchange Board of India (“SEBI”). The DRHP is available on the website of SEBI at www.sebi.gov.in as well as on the websites of the book running lead managers, ICICI Securities Limited, JM Financial Limited, J.P. Morgan India Private Limited, Jefferies India Private Limited and Nomura Financial Advisory and Securities (India) Private Limited, at https://www.icicisecurities.com, https://www.jmfl.com/, www.jpmipl.com, www.jefferies.com and www.nomuraholdings.com/company/group/asia/india/index.html respectively, and the websites of the stock exchange(s) at www.nseindia.com and www.bseindia.com, respectively. Any potential investor should note that investment in equity shares involves a high degree of risk and for details relating to such risk, see “Risk Factors” of the RHP, when available. Potential investors should not rely on the DRHP for any investment decision.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240820281018/en/